Daily Morning Note – 29 April 2019


Register HERE for MONDAY’s 11.15am webinar.

Archived webinars available.


Shares in the Asia Pacific region traded mixed on Monday morning, while markets in Japan are closed for a holiday. The S&P 500 and Nasdaq Composite finished the previous week at record highs. The S&P 500 climbed 0.5% to 2,939.88, an all-time closing high. The Nasdaq also ended the day up 0.3% at 8,146.40, as better-than-expected economic data offset a mixed batch of corporate earnings. First-quarter gross domestic product was 3.2%, the Commerce Department said on Friday, topping the consensus economist estimate of 2.5%, according to Dow Jones. Oil prices tumbled as much as 4% on Friday, extending early losses after President Donald Trump said he told OPEC to take action to temper fuel costs. Still, U.S. West Texas Intermediate crude futures settled $1.91 lower at $63.30 per barrel, plunging 2.9% on the day and ending the week down 1.1%.


Singapore Exchange Limited – Record derivatives volume to support earnings growth

Recommendation: ACCUMULATE (Maintained), Last Done price: S$7.37

Target Price: S$8.09, Analyst: Tin Min Ying

– 3Q19 revenue and net profit were in line with our estimates.

– Derivatives volume in 3Q19 surged 12% YoY, driven by China A50 futures
and iron ore derivatives. SDAV plunged 30% from a high base last year.

– Quarterly dividend per share declared at 7.5 cents, up 2.5 cents.

– We maintain Accumulate at a lower TP of S$8.09 (previously S$8.17) as we
peg our TP to 21.4x P/E, 1 SD below SGX’s 5-year mean. The lower TP is
due to higher DDAV partly offset by lower SDAV.

CapitaLand Mall Trust – Anticipating the anticipated

Maintain NEUTRAL; TP: S$2.21 (prev. S$2.09), Last: S$2.36, Analyst: Tara Wong

– 1Q19 NPI and DPU in line with our forecast.

– Stable portfolio occupancy and higher tenant retention rate.

– Funan pre-leased at 90% occupancy – on track to open in 2H2019.

– Still-weak rental reversions, dragged down by a wider mix of trade categories.
Tenant sales also slid 0.5% YoY.


China’s industrial profits pick up in March with 13.9% rise. Profits in March rose 13.9 per cent year-on-year to 589.52 billion yuan (S$120 billion), the National Bureau of Statistics (NBS) said on its website on Saturday, recovering from a 14 per cent fall in the first two months.

Labour costs to go up faster in 2019: MAS. Productivity growth has been on the decline – and the central bank anticipates it to come in below last year’s 2.5 per cent, especially as economic output falls in a cooler climate. Meanwhile, overall ULC should rise by around 2 per cent, against 0.5 per cent in 2018, the MAS said on Friday.

Singapore closer to becoming Asia’s debt restructuring hub. Singapore is a step closer to fulfilling its aim to become an international debt restructuring hub, akin to London or New York, after a landmark ruling by an English court to recognise the city-state’s new moratorium law for insolvency and corporate restructuring. This comes after the High Court of England and Wales last month recognised the reprieve granted by the Singapore High Court to H&C S Holdings from its creditors as the troubled iron ore trader works on its restructuring plan.

Keppel Corp ups limit of medium-term note programme to US$5b from US$3b. Offshore and marine company Keppel Corp has increased the investable limit of its multi-currency medium-term note programme to US$5 billion from US$3 billion. Net proceeds from the issue of the notes under the upsized programme will be used for general corporate or working capital purposes, the company said in a regulatory filing on Monday.

DBS Q1 profit up 9% to S$1.65b; to pay out 30 S cents per share for quarter. NIM expanded 1bps YoY to 1.88%. Loans grew by 5% YoY. Earnings per share came in at S$2.58, compared to S$2.38 previously. DBS declared a 30 Singapore cents per share dividend, consistent with the fiscal 2018’s full-year payout of S$1.20 per share.

Raffles Medical’s Q1 profit falls 13.7% on Chongqing hospital start-up costs. Raffles Medical Group on Monday morning reported a 13.7 per cent drop in its first-quarter net profit to S$13.6 million from S$15.8 million a year ago, due to start-up costs for Raffles Hospital Chongqing. The group’s revenue for the three months ended March 31 increased 6.7 per cent year on year to S$128.3 million.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR

Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: www.poems.com.sg > STOCKS > Research

Read the research report(s), available through the link(s) above, for complete information including important disclosures

Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com